EPOETIN ALFA-EPBX

EPOETIN ALFA-EPBX was reported 2244 times

EPOETIN ALFA-EPBX is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DOUBLE HETEROZYGOUS SICKLING DISORDERS 1 0.1250
1 ERYTHROPOIETIN DEFICIENCY ANAEMIA 1 0.1111
2 OTITIS MEDIA VIRAL 1 0.1111
3 FACIAL MYOKYMIA 1 0.0909
4 IRON BINDING CAPACITY UNSATURATED INCREASED 1 0.0769
5 ORTHOSTATIC HEADACHE 1 0.0625
6 MEDIASTINAL ABSCESS 8 0.0615
7 LARGE CELL LUNG CANCER STAGE IV 1 0.0526
8 IRON BINDING CAPACITY UNSATURATED DECREASED 1 0.0500
9 ANAL CANCER RECURRENT 1 0.0476
10 ANTI-ERYTHROPOIETIN ANTIBODY 1 0.0370
11 PERITONEAL DIALYSATE LEAKAGE 1 0.0303
12 CEREBELLAR STROKE 11 0.0281
13 WRONG PRODUCT STORED 7 0.0246
14 MALIGNANT SPINAL CORD COMPRESSION 1 0.0238
15 AUDITORY NERVE DISORDER 1 0.0227
16 PLASMA CELL MYELOMA IN REMISSION 1 0.0192
17 BLOOD ERYTHROPOIETIN ABNORMAL 1 0.0179
18 BLOOD ERYTHROPOIETIN DECREASED 1 0.0172
19 ADENOCARCINOMA METASTATIC 3 0.0146
20 COLD AGGLUTININS POSITIVE 1 0.0143
21 ACQUIRED DIAPHRAGMATIC EVENTRATION 5 0.0141
22 IRON BINDING CAPACITY TOTAL DECREASED 3 0.0136
23 WRONG STRENGTH 4 0.0121
24 LYMPHOCYTIC LYMPHOMA 1 0.0120
25 PRODUCT APPEARANCE CONFUSION 11 0.0119
26 ELLIPTOCYTOSIS 1 0.0111
27 ANTI-ERYTHROPOIETIN ANTIBODY NEGATIVE 1 0.0110
28 PERIPHERAL PULSE DECREASED 1 0.0103
29 JOB DISSATISFACTION 6 0.0092
30 SHUNT INFECTION 2 0.0088
31 TRANSFERRIN SATURATION INCREASED 3 0.0087
32 INTESTINAL BARRIER DYSFUNCTION 1 0.0086
33 NEUROSENSORY HYPOACUSIS 1 0.0083
34 BURKHOLDERIA TEST POSITIVE 1 0.0081
35 ANTI FACTOR VIII ANTIBODY INCREASED 1 0.0081
36 ECTHYMA 3 0.0075
37 LABILE HYPERTENSION 2 0.0072
38 ENZYME LEVEL ABNORMAL 1 0.0071
39 PLEUROPERITONEAL COMMUNICATION 1 0.0070
40 RETICULOCYTE COUNT DECREASED 3 0.0070
41 MEAN CELL HAEMOGLOBIN CONCENTRATION ABNORMAL 1 0.0062
42 HYPONATRAEMIC SYNDROME 2 0.0062
43 HAEMOGLOBINAEMIA 1 0.0058
44 PH URINE INCREASED 1 0.0058
45 ARTERIOVENOUS FISTULA OCCLUSION 1 0.0057
46 PRODUCT DOSE CONFUSION 2 0.0056
47 HYDROCHOLECYSTIS 1 0.0054
48 APLASIA PURE RED CELL 18 0.0052
49 ALCOHOLIC PANCREATITIS 1 0.0051
50 OPSOCLONUS MYOCLONUS 1 0.0047
51 BLOOD ETHANOL INCREASED 1 0.0045
52 GASTROOESOPHAGEAL SPHINCTER INSUFFICIENCY 1 0.0045
53 BREAST ATROPHY 1 0.0045
54 ALBUMIN GLOBULIN RATIO DECREASED 1 0.0043
55 LARYNX IRRITATION 1 0.0043
56 MEAN CELL VOLUME ABNORMAL 2 0.0042
57 PARATHYROIDECTOMY 2 0.0042
58 PRODUCT PACKAGING CONFUSION 10 0.0041
59 EYELID CYST 1 0.0039
60 HYPERPROTEINAEMIA 1 0.0038
61 KLEBSIELLA URINARY TRACT INFECTION 1 0.0038
62 FAECAL VOMITING 2 0.0038
63 PANCREATIC STEATOSIS 1 0.0037
64 BACTERIURIA 2 0.0035
65 ASBESTOSIS 1 0.0035
66 MALIGNANT NEOPLASM OF EYE 1 0.0035
67 CARDIAC FIBRILLATION 5 0.0034
68 FEAR OF DISEASE 6 0.0034
69 MEAN PLATELET VOLUME INCREASED 2 0.0033
70 CARBON DIOXIDE ABNORMAL 1 0.0032
71 HYPERCREATINAEMIA 1 0.0030
72 PNEUMONIA ESCHERICHIA 1 0.0029
73 MONOCYTE PERCENTAGE INCREASED 2 0.0028
74 GLOBULINS INCREASED 1 0.0027
75 MEAN CELL VOLUME INCREASED 7 0.0027
76 HEPATITIS B CORE ANTIBODY POSITIVE 1 0.0027
77 HEPATITIS B VIRUS TEST POSITIVE 1 0.0026
78 DEVICE OPERATIONAL ISSUE 11 0.0026
79 DEPENDENCE ON RESPIRATOR 1 0.0025
80 RENAL TRANSPLANT 9 0.0025
81 LYMPHOCYTE PERCENTAGE INCREASED 1 0.0025
82 CLUBBING 1 0.0025
83 INTERCEPTED PRODUCT DISPENSING ERROR 4 0.0024
84 MEAN PLATELET VOLUME DECREASED 2 0.0024
85 GENE MUTATION IDENTIFICATION TEST POSITIVE 1 0.0024
86 NAIL BED DISORDER 1 0.0023
87 HAEMANGIOMA OF SKIN 1 0.0023
88 MINERAL SUPPLEMENTATION 1 0.0022
89 BIOPSY BONE MARROW 1 0.0021
90 BLOOD IRON INCREASED 4 0.0021
91 INTENSIVE CARE 3 0.0021
92 GASTROINTESTINAL OBSTRUCTION 5 0.0021
93 BLOOD CREATINE ABNORMAL 1 0.0021
94 FULL BLOOD COUNT ABNORMAL 21 0.0020
95 HAEMOGLOBIN INCREASED 9 0.0020
96 BREAST CANCER MALE 1 0.0020
97 AORTIC VALVE CALCIFICATION 1 0.0019
98 MYELODYSPLASTIC SYNDROME TRANSFORMATION 1 0.0019
99 BLOOD ALBUMIN ABNORMAL 1 0.0019
100 GASTRIC ANTRAL VASCULAR ECTASIA 1 0.0019
101 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
102 VASCULAR CALCIFICATION 2 0.0019
103 NEUTROPHIL PERCENTAGE DECREASED 1 0.0019
104 WHITE BLOOD CELL DISORDER 5 0.0019
105 BLOOD IMMUNOGLOBULIN A INCREASED 1 0.0019
106 IRON OVERLOAD 2 0.0019
107 EOSINOPHIL PERCENTAGE INCREASED 1 0.0018
108 PRODUCT NAME CONFUSION 2 0.0018
109 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 3 0.0018
110 ANXIETY DISORDER 6 0.0018
111 CARBON DIOXIDE DECREASED 2 0.0017
112 PRODUCT CONTAMINATION 6 0.0017
113 COLON CANCER STAGE IV 1 0.0017
114 HAEMATOMA MUSCLE 2 0.0017
115 BONE MARROW DISORDER 5 0.0017
116 GASTROINTESTINAL POLYP HAEMORRHAGE 1 0.0017
117 BLOOD IMMUNOGLOBULIN M INCREASED 1 0.0016
118 HAEMOGLOBIN DECREASED 167 0.0016
119 ENDOMETRIAL ADENOCARCINOMA 1 0.0016
120 HAEMOGLOBIN ABNORMAL 10 0.0016
121 DIALYSIS 22 0.0015
122 PNEUMONIA NECROTISING 1 0.0015
123 PRODUCT LABEL CONFUSION 9 0.0015
124 BLOOD IMMUNOGLOBULIN A DECREASED 1 0.0015
125 BICYTOPENIA 3 0.0015
126 PROSTATOMEGALY 6 0.0015
127 TRANSFUSION 16 0.0015
128 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 1 0.0015
129 OESOPHAGITIS ULCERATIVE 1 0.0015
130 COMPUTERISED TOMOGRAM THORAX ABNORMAL 1 0.0015
131 NEUROENDOCRINE CARCINOMA 1 0.0014
132 RED CELL DISTRIBUTION WIDTH INCREASED 6 0.0014
133 DERMATITIS EXFOLIATIVE GENERALISED 5 0.0014
134 HAEMATOCRIT DECREASED 28 0.0014
135 ANAEMIA MACROCYTIC 3 0.0014
136 ANTIBODY TEST ABNORMAL 1 0.0014
137 HEPATITIS ACUTE 9 0.0014
138 DIVERTICULUM INTESTINAL 6 0.0014
139 DIFFERENTIATION SYNDROME 1 0.0014
140 NORMOCYTIC ANAEMIA 2 0.0014
141 AMYLASE INCREASED 5 0.0014
142 CORNEAL DEPOSITS 1 0.0013
143 FULL BLOOD COUNT DECREASED 27 0.0013
144 SERUM FERRITIN INCREASED 7 0.0013
145 CHLAMYDIAL INFECTION 1 0.0013
146 BASOPHIL COUNT INCREASED 1 0.0013
147 HOSPICE CARE 13 0.0013
148 MYOGLOBIN BLOOD INCREASED 2 0.0013
149 MALIGNANT ASCITES 1 0.0013
150 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 1 0.0013
151 BLISTER INFECTED 1 0.0013
152 FEAR OF FALLING 1 0.0012
153 MEAN CELL HAEMOGLOBIN INCREASED 2 0.0012
154 SPLEEN DISORDER 2 0.0012
155 HEPATIC CANCER METASTATIC 1 0.0012
156 TREATMENT DELAYED 2 0.0012
157 FANCONI SYNDROME ACQUIRED 2 0.0011
158 ISCHAEMIC STROKE 20 0.0011
159 BLOOD MAGNESIUM INCREASED 1 0.0011
160 PRODUCT PRESCRIBING ERROR 26 0.0011
161 HAEMORRHAGIC ARTERIOVENOUS MALFORMATION 1 0.0011
162 BLOOD UREA ABNORMAL 1 0.0011
163 INFECTED SKIN ULCER 2 0.0011
164 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
165 RED BLOOD CELL COUNT DECREASED 30 0.0010
166 NEUTROPENIC INFECTION 1 0.0010
167 APLASIA 2 0.0010
168 DECREASED INTEREST 6 0.0010
169 BLADDER CANCER RECURRENT 1 0.0010
170 ACQUIRED HAEMOPHILIA 1 0.0010
171 BLOOD IMMUNOGLOBULIN M DECREASED 1 0.0010
172 BRAIN HYPOXIA 1 0.0010
173 CYSTITIS HAEMORRHAGIC 4 0.0010
174 MYELOFIBROSIS 3 0.0010
175 HYPERURICAEMIA 4 0.0010
176 LIGHT CHAIN ANALYSIS INCREASED 1 0.0010
177 MICROCYTIC ANAEMIA 2 0.0010
178 BLAST CELL COUNT INCREASED 1 0.0010
179 ASTERIXIS 1 0.0009
180 BLOOD IRON DECREASED 11 0.0009
181 CLAUSTROPHOBIA 1 0.0009
182 RENAL COLIC 2 0.0009
183 COMPLICATIONS OF TRANSPLANTED KIDNEY 2 0.0009
184 NEPHROGENIC DIABETES INSIPIDUS 1 0.0009
185 LUMBAR RADICULOPATHY 1 0.0009
186 RESPIRATORY TRACT INFECTION VIRAL 2 0.0009
187 BLADDER OPERATION 1 0.0009
188 NEPHROCALCINOSIS 1 0.0008
189 FULL BLOOD COUNT INCREASED 1 0.0008
190 MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0008
191 WRONG DOSE 2 0.0008
192 BLOOD IMMUNOGLOBULIN G INCREASED 1 0.0008
193 MONOCYTE COUNT DECREASED 1 0.0008
194 LARGE INTESTINE INFECTION 1 0.0008
195 HAEMATOCRIT ABNORMAL 1 0.0008
196 SYRINGE ISSUE 14 0.0008
197 PLATELET DISORDER 2 0.0008
198 BLOOD COUNT ABNORMAL 12 0.0008
199 CANCER PAIN 2 0.0008
200 LACTOSE INTOLERANCE 2 0.0008
201 DIFFUSE LARGE B-CELL LYMPHOMA 6 0.0008
202 HYPOACUSIS 33 0.0008
203 DRUG CLEARANCE DECREASED 1 0.0008
204 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0007
205 BLOOD PHOSPHORUS INCREASED 2 0.0007
206 RED BLOOD CELL COUNT INCREASED 2 0.0007
207 DISCHARGE 1 0.0007
208 FEBRILE BONE MARROW APLASIA 3 0.0007
209 BLADDER TRANSITIONAL CELL CARCINOMA 1 0.0007
210 HAEMOTHORAX 2 0.0007
211 BLOOD PARATHYROID HORMONE INCREASED 2 0.0007
212 NODAL RHYTHM 1 0.0007
213 BILIARY DILATATION 1 0.0007
214 BLOOD CREATINE INCREASED 3 0.0007
215 NEPHRECTOMY 1 0.0007
216 GASTROINTESTINAL WALL THICKENING 1 0.0007
217 MENTAL FATIGUE 1 0.0007
218 URINARY TRACT DISORDER 3 0.0007
219 SUSPECTED OFF LABEL USE 3 0.0007
220 EMERGENCY CARE 2 0.0007
221 INTELLECTUAL DISABILITY 1 0.0007
222 LIPASE INCREASED 5 0.0007
223 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
224 NEURITIS 1 0.0006
225 NEPHROPATHY 6 0.0006
226 BACTERIAL VAGINOSIS 1 0.0006
227 FOREIGN BODY IN THROAT 2 0.0006
228 LIMB DEFORMITY 1 0.0006
229 MYELODYSPLASTIC SYNDROME 9 0.0006
230 ANTIPHOSPHOLIPID SYNDROME 1 0.0006
231 GLYCOSYLATED HAEMOGLOBIN DECREASED 1 0.0006
232 AORTIC VALVE DISEASE 1 0.0006
233 HYPERVOLAEMIA 3 0.0006
234 NEAR DEATH EXPERIENCE 2 0.0006
235 APPETITE DISORDER 4 0.0006
236 IGA NEPHROPATHY 1 0.0006
237 MEDICAL PROCEDURE 1 0.0006
238 AGRANULOCYTOSIS 11 0.0006
239 BONE MARROW FAILURE 12 0.0006
240 EXPOSURE TO SARS-COV-2 1 0.0006
241 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 6 0.0006
242 CACHEXIA 3 0.0006
243 CERVICAL SPINAL STENOSIS 1 0.0006
244 BLOOD CREATININE ABNORMAL 2 0.0006
245 MASTECTOMY 1 0.0006
246 ANAEMIA 109 0.0006
247 BREAST PAIN 6 0.0006
248 AORTIC VALVE STENOSIS 1 0.0006
249 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
250 PNEUMONIA KLEBSIELLA 1 0.0005
251 CHEMOTHERAPY 2 0.0005
252 BLOOD BICARBONATE DECREASED 1 0.0005
253 COMMUNICATION DISORDER 2 0.0005
254 HAEMOLYSIS 4 0.0005
255 ATELECTASIS 5 0.0005
256 PANIC DISORDER 2 0.0005
257 CARCINOEMBRYONIC ANTIGEN INCREASED 1 0.0005
258 PNEUMONIA CYTOMEGALOVIRAL 1 0.0005
259 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4 0.0005
260 RHINOVIRUS INFECTION 2 0.0005
261 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
262 OCCULT BLOOD POSITIVE 1 0.0005
263 PNEUMONIA FUNGAL 2 0.0005
264 PRODUCT DISPENSING ERROR 11 0.0005
265 EMPYEMA 1 0.0005
266 AZOTAEMIA 2 0.0005
267 BLOOD DISORDER 4 0.0005
268 BLOOD TEST ABNORMAL 7 0.0005
269 MENISCUS INJURY 3 0.0005
270 CHANGE OF BOWEL HABIT 1 0.0005
271 CHOLANGITIS SCLEROSING 1 0.0005
272 POLYCYTHAEMIA 1 0.0005
273 DEATH 416 0.0005
274 NEEDLE ISSUE 14 0.0005
275 INSULIN RESISTANCE 1 0.0005
276 LIVEDO RETICULARIS 1 0.0005
277 SWELLING OF EYELID 3 0.0005
278 THERAPY INTERRUPTED 34 0.0005
279 HOSPITALISATION 73 0.0005
280 DEVICE CONNECTION ISSUE 1 0.0005
281 HYPERPYREXIA 2 0.0005
282 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
283 IMMUNODEFICIENCY 7 0.0005
284 PRODUCT DISPENSING ISSUE 2 0.0005
285 HYPERPHOSPHATAEMIA 1 0.0005
286 BLOOD MAGNESIUM DECREASED 4 0.0005
287 INFUSION SITE BRUISING 1 0.0005
288 CERVICAL DYSPLASIA 1 0.0005
289 ONYCHOMYCOSIS 2 0.0005
290 NOSOCOMIAL INFECTION 1 0.0005
291 CLOSTRIDIUM TEST POSITIVE 1 0.0005
292 QUALITY OF LIFE DECREASED 6 0.0004
293 DIVERTICULUM INTESTINAL HAEMORRHAGIC 1 0.0004
294 SICKLE CELL ANAEMIA WITH CRISIS 7 0.0004
295 WRONG PRODUCT ADMINISTERED 3 0.0004
296 VASCULAR DEVICE INFECTION 2 0.0004
297 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
298 HAEMATOCRIT INCREASED 1 0.0004
299 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
300 DEVICE MECHANICAL ISSUE 6 0.0004
301 METASTATIC MALIGNANT MELANOMA 1 0.0004
302 CYTOMEGALOVIRUS COLITIS 1 0.0004
303 NEPHROGENIC ANAEMIA 2 0.0004
304 RENAL FUNCTION TEST ABNORMAL 2 0.0004
305 RENAL DISORDER 20 0.0004
306 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 11 0.0004
307 SPLENOMEGALY 5 0.0004
308 OXYGEN CONSUMPTION INCREASED 1 0.0004
309 HAEMATOLOGICAL INFECTION 1 0.0004
310 FEBRILE NEUTROPENIA 27 0.0004
311 STAPHYLOCOCCAL SEPSIS 2 0.0004
312 RASH MACULO-PAPULAR 9 0.0004
313 BLOOD PRESSURE ABNORMAL 8 0.0004
314 PROTEIN URINE PRESENT 2 0.0004
315 METASTASES TO PERITONEUM 1 0.0004
316 DEVICE PHYSICAL PROPERTY ISSUE 3 0.0004
317 PRODUCT TEMPERATURE EXCURSION ISSUE 2 0.0004
318 PLATELET COUNT INCREASED 5 0.0004
319 BLOOD ALBUMIN DECREASED 3 0.0004
320 ANORECTAL DISCOMFORT 2 0.0004
321 OFF LABEL USE 329 0.0004
322 BODY HEIGHT DECREASED 4 0.0004
323 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
324 MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0004
325 PRESYNCOPE 9 0.0004
326 EAR CONGESTION 1 0.0004
327 DECUBITUS ULCER 3 0.0004
328 PRODUCT PRESCRIBING ISSUE 8 0.0004
329 PLEURITIC PAIN 1 0.0004
330 THROMBOCYTOPENIA 40 0.0004
331 PRODUCT LEAKAGE 2 0.0004
332 MULTIPLE USE OF SINGLE-USE PRODUCT 2 0.0004
333 CHRONIC KIDNEY DISEASE 27 0.0004
334 CEREBRAL THROMBOSIS 1 0.0004
335 CHOLECYSTITIS ACUTE 2 0.0004
336 OESOPHAGEAL STENOSIS 1 0.0004
337 HAEMATOLOGICAL MALIGNANCY 1 0.0004
338 INTENTIONAL DOSE OMISSION 10 0.0004
339 CARDIAC VALVE DISEASE 2 0.0003
340 LIP PAIN 1 0.0003
341 PARAPLEGIA 1 0.0003
342 DYSPNOEA EXERTIONAL 13 0.0003
343 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
344 ELECTROLYTE IMBALANCE 4 0.0003
345 STRESS CARDIOMYOPATHY 2 0.0003
346 DEVICE POWER SOURCE ISSUE 1 0.0003
347 HIP FRACTURE 11 0.0003
348 PANCYTOPENIA 19 0.0003
349 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 2 0.0003
350 HYPERCAPNIA 1 0.0003
351 HIV INFECTION 1 0.0003
352 CENTRAL VENOUS CATHETERISATION 1 0.0003
353 PLATELET COUNT ABNORMAL 2 0.0003
354 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
355 INTRACARDIAC THROMBUS 1 0.0003
356 IRON DEFICIENCY ANAEMIA 3 0.0003
357 LARYNGEAL OEDEMA 2 0.0003
358 PRODUCT DISTRIBUTION ISSUE 3 0.0003
359 DIARRHOEA HAEMORRHAGIC 3 0.0003
360 BLADDER PAIN 1 0.0003
361 HYPERKALAEMIA 11 0.0003
362 WHITE BLOOD CELL COUNT ABNORMAL 2 0.0003
363 DRUG SPECIFIC ANTIBODY PRESENT 2 0.0003
364 LYMPHOCYTE COUNT INCREASED 1 0.0003
365 MUCOSAL INFLAMMATION 8 0.0003
366 PERICARDIAL EFFUSION 7 0.0003
367 CORONAVIRUS INFECTION 2 0.0003
368 SOPOR 4 0.0003
369 ILLNESS 31 0.0003
370 CARDIAC FAILURE ACUTE 2 0.0003
371 PLATELET COUNT DECREASED 32 0.0003
372 BLOOD UREA INCREASED 5 0.0003
373 TOXIC SKIN ERUPTION 3 0.0003
374 METASTASES TO SPINE 1 0.0003
375 ACUTE KIDNEY INJURY 45 0.0003
376 NEUTROPHIL COUNT INCREASED 3 0.0003
377 BRONCHOPNEUMONIA 1 0.0003
378 HEPATIC FIBROSIS 1 0.0003
379 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
380 HANGOVER 1 0.0003
381 LYMPHOCYTE COUNT DECREASED 5 0.0003
382 LUNG TRANSPLANT 1 0.0003
383 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
384 PRODUCT SUPPLY ISSUE 2 0.0003
385 DERMATITIS BULLOUS 2 0.0003
386 MONOCYTE COUNT INCREASED 1 0.0003
387 MOUTH HAEMORRHAGE 2 0.0003
388 RESPIRATORY TRACT INFECTION 7 0.0003
389 HYDRONEPHROSIS 2 0.0003
390 PANCREATITIS ACUTE 6 0.0003
391 BLOOD CALCIUM DECREASED 3 0.0003
392 ANHEDONIA 7 0.0003
393 AUTOIMMUNE THYROIDITIS 1 0.0003
394 CATHETER SITE INFECTION 1 0.0003
395 FACE INJURY 1 0.0003
396 TROPONIN INCREASED 2 0.0003
397 DIABETES MELLITUS 20 0.0003
398 INTERCEPTED PRODUCT ADMINISTRATION ERROR 2 0.0003
399 GASTRIC HAEMORRHAGE 3 0.0003
400 ACUTE RESPIRATORY FAILURE 5 0.0003
401 POST PROCEDURAL HAEMORRHAGE 3 0.0003
402 EJECTION FRACTION DECREASED 4 0.0003
403 BRAIN FOG 4 0.0003
404 HYPERPHAGIA 1 0.0003
405 ATRIAL FLUTTER 2 0.0003
406 POLYNEUROPATHY 3 0.0003
407 SENSORY LOSS 2 0.0002
408 ORGAN FAILURE 1 0.0002
409 MENTAL IMPAIRMENT 6 0.0002
410 C-REACTIVE PROTEIN INCREASED 9 0.0002
411 NOCTURIA 3 0.0002
412 TASTE DISORDER 5 0.0002
413 BLOOD POTASSIUM INCREASED 4 0.0002
414 BACK DISORDER 4 0.0002
415 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
416 LEG AMPUTATION 1 0.0002
417 EMBOLISM 2 0.0002
418 SECOND PRIMARY MALIGNANCY 2 0.0002
419 CONGESTIVE CARDIOMYOPATHY 1 0.0002
420 WHITE BLOOD CELL COUNT DECREASED 26 0.0002
421 GAIT INABILITY 8 0.0002
422 ONYCHOMADESIS 1 0.0002
423 INFUSION SITE ERYTHEMA 2 0.0002
424 NEUTROPENIA 32 0.0002
425 AORTIC VALVE INCOMPETENCE 1 0.0002
426 EATING DISORDER 5 0.0002
427 FACIAL PARALYSIS 2 0.0002
428 WHITE BLOOD CELL COUNT INCREASED 9 0.0002
429 ANURIA 2 0.0002
430 METASTATIC NEOPLASM 1 0.0002
431 MYOPATHY 2 0.0002
432 HEPATIC LESION 1 0.0002
433 MONOPLEGIA 1 0.0002
434 BONE CANCER 1 0.0002
435 BLOOD CREATININE INCREASED 15 0.0002
436 EOSINOPHILIA 4 0.0002
437 MELANOCYTIC NAEVUS 1 0.0002
438 ASTHENIA 85 0.0002
439 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
440 GASTROINTESTINAL INFECTION 2 0.0002
441 THERAPY NON-RESPONDER 10 0.0002
442 ANAL INCONTINENCE 2 0.0002
443 IRON DEFICIENCY 1 0.0002
444 LIMB INJURY 6 0.0002
445 GINGIVAL BLEEDING 3 0.0002
446 PRODUCT AVAILABILITY ISSUE 5 0.0002
447 IMMUNE THROMBOCYTOPENIA 1 0.0002
448 EAR DISORDER 1 0.0002
449 PROSTATIC SPECIFIC ANTIGEN INCREASED 3 0.0002
450 SHOCK 5 0.0002
451 COLORECTAL CANCER STAGE IV 1 0.0002
452 HYPOKALAEMIA 10 0.0002
453 COVID-19 38 0.0002
454 ARTHRITIS INFECTIVE 1 0.0002
455 APHONIA 3 0.0002
456 ARTERIOSCLEROSIS 2 0.0002
457 SQUAMOUS CELL CARCINOMA 2 0.0002
458 LEUKAEMIA 2 0.0002
459 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
460 SPINAL DISORDER 2 0.0002
461 RECTAL HAEMORRHAGE 9 0.0002
462 HYPOVOLAEMIC SHOCK 1 0.0002
463 KIDNEY TRANSPLANT REJECTION 1 0.0002
464 PRODUCT DOSE OMISSION ISSUE 61 0.0002
465 SEPTIC SHOCK 9 0.0002
466 LABORATORY TEST ABNORMAL 6 0.0002
467 BREATH SOUNDS ABNORMAL 1 0.0002
468 ABDOMINAL TENDERNESS 1 0.0002
469 NEOPLASM PROGRESSION 7 0.0002
470 PULMONARY OEDEMA 9 0.0002
471 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 11 0.0002
472 SALIVARY HYPERSECRETION 2 0.0002
473 CARDIAC FAILURE 16 0.0002
474 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
475 FEEDING DISORDER 4 0.0002
476 DRUG LEVEL DECREASED 2 0.0002
477 AMMONIA INCREASED 1 0.0002
478 FEMORAL NECK FRACTURE 1 0.0002
479 CEREBRAL ISCHAEMIA 1 0.0002
480 PERIPHERAL VASCULAR DISORDER 1 0.0002
481 RENAL IMPAIRMENT 16 0.0002
482 DEVICE ISSUE 17 0.0002
483 RENAL FAILURE 25 0.0002
484 FOOD POISONING 1 0.0002
485 ANAL FISSURE 1 0.0002
486 OVERWEIGHT 1 0.0002
487 INJECTION SITE DISCHARGE 1 0.0002
488 SKIN CANCER 4 0.0002
489 BRUXISM 1 0.0002
490 GINGIVITIS 1 0.0002
491 SKIN LACERATION 2 0.0002
492 HYDROCEPHALUS 1 0.0002
493 PULMONARY THROMBOSIS 2 0.0002
494 ASPIRATION 2 0.0002
495 JAW DISORDER 1 0.0002
496 STAPHYLOCOCCAL INFECTION 6 0.0002
497 DEAFNESS UNILATERAL 1 0.0002
498 NERVE INJURY 2 0.0002
499 HEART RATE ABNORMAL 1 0.0002
500 PNEUMONIA 58 0.0002
501 DEMENTIA 5 0.0002
502 ANGIOPATHY 1 0.0002
503 RESPIRATORY FAILURE 13 0.0002
504 ACUTE PULMONARY OEDEMA 1 0.0002
505 FISTULA 2 0.0002
506 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
507 COLECTOMY 1 0.0002
508 MITRAL VALVE INCOMPETENCE 2 0.0002
509 IMPAIRED DRIVING ABILITY 2 0.0002
510 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
511 NEPHROLITHIASIS 8 0.0002
512 BLOOD URIC ACID INCREASED 1 0.0002
513 VASCULITIS 2 0.0002
514 HYPOVOLAEMIA 1 0.0002
515 BONE PAIN 10 0.0002
516 ENERGY INCREASED 1 0.0002
517 ATAXIA 2 0.0002
518 BACTERAEMIA 2 0.0002
519 CARDIAC PACEMAKER INSERTION 1 0.0002
520 WRIST FRACTURE 2 0.0002
521 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
522 HEPATITIS CHOLESTATIC 1 0.0002
523 HYPOGLYCAEMIA 8 0.0002
524 END STAGE RENAL DISEASE 3 0.0002
525 CYTOPENIA 2 0.0002
526 INTERCEPTED PRODUCT PREPARATION ERROR 2 0.0002
527 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
528 GYNAECOMASTIA 5 0.0002
529 GENERALISED OEDEMA 2 0.0002
530 PHARYNGITIS 2 0.0002
531 BACTERIAL INFECTION 3 0.0002
532 INFUSION SITE EXTRAVASATION 1 0.0002
533 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
534 HEPATIC CIRRHOSIS 3 0.0002
535 BLOOD SODIUM DECREASED 3 0.0002
536 INFUSION SITE SWELLING 1 0.0002
537 HYPOCALCAEMIA 3 0.0002
538 PROTEINURIA 3 0.0002
539 FOREIGN BODY SENSATION IN EYES 1 0.0002
540 HEPATIC CYTOLYSIS 2 0.0002
541 DEVICE DEPLOYMENT ISSUE 2 0.0002
542 METABOLIC ACIDOSIS 5 0.0002
543 POST PROCEDURAL COMPLICATION 3 0.0002
544 OCCUPATIONAL EXPOSURE TO PRODUCT 1 0.0002
545 INFUSION SITE PAIN 2 0.0002
546 HAEMORRHOIDS 3 0.0002
547 SPEECH DISORDER 8 0.0002
548 ORAL CANDIDIASIS 2 0.0002
549 BREAST MASS 1 0.0001
550 PRODUCT PHYSICAL ISSUE 3 0.0001
551 PRODUCT STORAGE ERROR 13 0.0001
552 PRODUCT ADMINISTRATION ERROR 3 0.0001
553 PLEURAL EFFUSION 9 0.0001
554 NEUTROPHIL COUNT DECREASED 6 0.0001
555 EPISTAXIS 11 0.0001
556 RASH ERYTHEMATOUS 7 0.0001
557 RESPIRATORY DISTRESS 4 0.0001
558 ORAL DISCOMFORT 2 0.0001
559 FORMICATION 1 0.0001
560 HAEMOPTYSIS 4 0.0001
561 NECK PAIN 8 0.0001
562 DEHYDRATION 19 0.0001
563 DEVICE OCCLUSION 2 0.0001
564 CARDIOGENIC SHOCK 2 0.0001
565 GRAFT VERSUS HOST DISEASE 1 0.0001
566 LETHARGY 8 0.0001
567 CELLULITIS 7 0.0001
568 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
569 FAECES SOFT 1 0.0001
570 CARDIAC FAILURE CONGESTIVE 11 0.0001
571 ACUTE MYOCARDIAL INFARCTION 4 0.0001
572 HYPOPHOSPHATAEMIA 1 0.0001
573 DISEASE PROGRESSION 16 0.0001
574 CEREBRAL DISORDER 1 0.0001
575 COLON CANCER 2 0.0001
576 BLOOD POTASSIUM DECREASED 4 0.0001
577 APHASIA 4 0.0001
578 HAEMODYNAMIC INSTABILITY 1 0.0001
579 HYPERTHERMIA 1 0.0001
580 ACIDOSIS 1 0.0001
581 INSURANCE ISSUE 2 0.0001
582 DEVICE RELATED INFECTION 2 0.0001
583 ATRIOVENTRICULAR BLOCK 1 0.0001
584 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
585 PELVIC FRACTURE 1 0.0001
586 ACUTE MYELOID LEUKAEMIA 2 0.0001
587 GASTROINTESTINAL INFLAMMATION 1 0.0001
588 MULTIPLE ALLERGIES 1 0.0001
589 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
590 HAEMATOCHEZIA 7 0.0001
591 PRODUCTIVE COUGH 6 0.0001
592 WEIGHT DECREASED 35 0.0001
593 BLOOD PRESSURE FLUCTUATION 3 0.0001
594 BLISTER 7 0.0001
595 LOCALISED INFECTION 3 0.0001
596 DIARRHOEA 80 0.0001
597 ATRIAL FIBRILLATION 12 0.0001
598 MALAISE 54 0.0001
599 ASPHYXIA 1 0.0001
600 METASTASES TO BONE 2 0.0001
601 CYTOMEGALOVIRUS INFECTION 2 0.0001
602 LEUKOPENIA 6 0.0001
603 DYSPHONIA 7 0.0001
604 GASTROINTESTINAL HAEMORRHAGE 10 0.0001
605 HAEMODIALYSIS 1 0.0001
606 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
607 SKIN EXFOLIATION 10 0.0001
608 BLOOD PRESSURE INCREASED 18 0.0001
609 CIRCULATORY COLLAPSE 2 0.0001
610 GASTRIC DISORDER 4 0.0001
611 CARDIAC OPERATION 1 0.0001
612 MUSCLE STRAIN 1 0.0001
613 CARDIAC MURMUR 1 0.0001
614 DEVICE DEFECTIVE 2 0.0001
615 ORTHOSTATIC HYPOTENSION 2 0.0001
616 METASTASES TO LIVER 2 0.0001
617 BRADYCARDIA 6 0.0001
618 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
619 GENERAL PHYSICAL HEALTH DETERIORATION 13 0.0001
620 FACIAL PAIN 1 0.0001
621 THROMBOSIS 9 0.0001
622 CEREBRAL HAEMORRHAGE 4 0.0001
623 HAEMOLYTIC ANAEMIA 1 0.0001
624 URINARY TRACT INFECTION 19 0.0001
625 FREQUENT BOWEL MOVEMENTS 3 0.0001
626 OROPHARYNGEAL DISCOMFORT 1 0.0001
627 LEUKOCYTOSIS 2 0.0001
628 TOOTHACHE 2 0.0001
629 DEVICE DELIVERY SYSTEM ISSUE 3 0.0001
630 SKIN LESION 3 0.0001
631 SKIN DISCOLOURATION 5 0.0001
632 NERVE COMPRESSION 1 0.0001
633 MENTAL STATUS CHANGES 3 0.0001
634 ERYTHEMA MULTIFORME 1 0.0001
635 FLANK PAIN 1 0.0001
636 FRACTURE 2 0.0001
637 NEUROPATHY PERIPHERAL 10 0.0001
638 NEOPLASM MALIGNANT 7 0.0001
639 ANGINA PECTORIS 3 0.0001
640 HYPOTENSION 21 0.0001
641 INCREASED APPETITE 2 0.0001
642 HYPERSOMNIA 3 0.0001
643 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
644 LOWER LIMB FRACTURE 2 0.0001
645 INTERSTITIAL LUNG DISEASE 5 0.0001
646 AUTOIMMUNE DISORDER 1 0.0001
647 PLASMA CELL MYELOMA 4 0.0001
648 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
649 LUNG DISORDER 5 0.0001
650 HEPATOMEGALY 1 0.0001
651 KNEE OPERATION 1 0.0001
652 URINARY INCONTINENCE 3 0.0001
653 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
654 SINUS DISORDER 2 0.0001
655 PRODUCT USE IN UNAPPROVED INDICATION 25 0.0001
656 INABILITY TO AFFORD MEDICATION 1 0.0001
657 FATIGUE 78 0.0001
658 CYTOKINE RELEASE SYNDROME 2 0.0001
659 HEPATIC FAILURE 3 0.0001
660 BACK PAIN 23 0.0001
661 CONFUSIONAL STATE 16 0.0001
662 VERTIGO 6 0.0001
663 PRODUCT PREPARATION ERROR 2 0.0001
664 RIB FRACTURE 2 0.0001
665 INFECTION 14 0.0001
666 HAEMORRHAGE 10 0.0001
667 MUSCULOSKELETAL PAIN 5 0.0001
668 INJECTION SITE DISCOMFORT 1 0.0001
669 HEAD INJURY 3 0.0001
670 INCONTINENCE 1 0.0001
671 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
672 CYSTITIS 3 0.0001
673 JOINT INJURY 2 0.0001
674 MOVEMENT DISORDER 3 0.0001
675 HEREDITARY ANGIOEDEMA 1 0.0001
676 FALL 31 0.0001
677 DECREASED ACTIVITY 1 0.0001
678 FAECES DISCOLOURED 2 0.0001
679 BACK INJURY 1 0.0001
680 MYOCARDIAL INFARCTION 16 0.0001
681 CONSTIPATION 20 0.0001
682 OESOPHAGITIS 1 0.0001
683 GASTROINTESTINAL PAIN 1 0.0001
684 PERIPHERAL SWELLING 14 0.0001
685 MELAENA 2 0.0001
686 DECREASED APPETITE 21 0.0001
687 DENTAL CARIES 1 0.0001
688 BLOOD PRESSURE DECREASED 6 0.0001
689 FOOT DEFORMITY 1 0.0001
690 STEVENS-JOHNSON SYNDROME 2 0.0001
691 SKIN DISORDER 3 0.0001
692 TOOTH DISORDER 2 0.0001
693 MALNUTRITION 1 0.0001
694 ORAL PAIN 2 0.0001
695 THROAT IRRITATION 4 0.0001
696 TYPE 2 DIABETES MELLITUS 3 0.0001
697 INTESTINAL PERFORATION 1 0.0001
698 ADVERSE DRUG REACTION 8 0.0001
699 HEART RATE IRREGULAR 2 0.0001
700 FLATULENCE 5 0.0001
701 INTERNAL HAEMORRHAGE 1 0.0001
702 MEMORY IMPAIRMENT 12 0.0001
703 HERPES ZOSTER 5 0.0001
704 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
705 MADAROSIS 1 0.0001
706 CARDIAC DISORDER 8 0.0001
707 DEVICE MALFUNCTION 6 0.0001
708 CHILLS 10 0.0001
709 DYSPNOEA 48 0.0001
710 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
711 PYREXIA 29 0.0001
712 ACCIDENT 1 0.0001
713 HYPERLIPIDAEMIA 1 0.0001
714 GAIT DISTURBANCE 16 0.0001
715 MOBILITY DECREASED 6 0.0001
716 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
717 CEREBROVASCULAR ACCIDENT 14 0.0001
718 CRYING 3 0.0001
719 STOMATITIS 5 0.0001
720 FIBROMYALGIA 2 0.0001
721 NEURALGIA 2 0.0001
722 COUGH 23 0.0001
723 MUSCLE SPASMS 15 0.0001
724 ENCEPHALOPATHY 2 0.0001
725 MUSCLE SPASTICITY 1 0.0001
726 DYSPEPSIA 8 0.0001
727 CARDIOMEGALY 1 0.0001
728 HYPERCALCAEMIA 1 0.0001
729 SEPSIS 9 0.0001
730 HYPERTENSION 17 0.0001
731 SYNCOPE 8 0.0001
732 PRODUCT USE ISSUE 15 0.0001
733 COLITIS 3 0.0001
734 MUSCLE ATROPHY 1 0.0001
735 VOMITING 37 0.0001
736 FLUID RETENTION 4 0.0001
737 TREMOR 13 0.0001
738 HYPOPHAGIA 2 0.0001
739 CHEST DISCOMFORT 8 0.0001
740 THERAPY CESSATION 4 0.0001
741 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
742 INFLAMMATION 4 0.0001
743 HIATUS HERNIA 1 0.0001
744 DEEP VEIN THROMBOSIS 5 0.0001
745 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
746 ABDOMINAL DISTENSION 8 0.0001
747 PRODUCT DOSE OMISSION 5 0.0001
748 DEAFNESS 2 0.0001
749 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
750 ARTHRITIS 6 0.0001
751 JOINT STIFFNESS 2 0.0001
752 BEDRIDDEN 1 0.0001
753 IMMUNE SYSTEM DISORDER 1 0.0001
754 DISORIENTATION 3 0.0001
755 BREAST CANCER FEMALE 2 0.0001
756 JAUNDICE 2 0.0001
757 THROAT TIGHTNESS 2 0.0001
758 OEDEMA PERIPHERAL 9 0.0001
759 BLINDNESS 3 0.0001
760 IMPAIRED GASTRIC EMPTYING 1 0.0001
761 NAUSEA 58 0.0001
762 ACUTE HEPATIC FAILURE 1 0.0001
763 CONTUSION 7 0.0001
764 VISUAL IMPAIRMENT 9 0.0001
765 ANAPHYLACTIC REACTION 4 0.0001
766 DIVERTICULITIS 2 0.0001
767 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 13 0.0001
768 PROCEDURAL PAIN 2 0.0001
769 ARTHROPATHY 4 0.0001
770 HYPOMAGNESAEMIA 1 0.0001
771 HUNGER 1 0.0001
772 COORDINATION ABNORMAL 1 0.0001
773 HYPONATRAEMIA 4 0.0001
774 BLINDNESS UNILATERAL 1 0.0001
775 LYMPHOPENIA 1 0.0001
776 HEART RATE INCREASED 7 0.0001
777 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
778 HYPERHIDROSIS 9 0.0001
779 PARALYSIS 1 0.0001
780 BALANCE DISORDER 6 0.0001
781 PARAESTHESIA ORAL 1 0.0001
782 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
783 DYSSTASIA 2 0.0001
784 MALIGNANT NEOPLASM PROGRESSION 7 0.0001
785 SURGERY 4 0.0001
786 CARDIOMYOPATHY 1 0.0001
787 LIVER DISORDER 3 0.0001
788 DYSGEUSIA 5 0.0001
789 GASTROINTESTINAL DISORDER 6 0.0001
790 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
791 RESPIRATORY DISORDER 2 0.0001
792 LACRIMATION INCREASED 2 0.0001
793 ECONOMIC PROBLEM 1 0.0001
794 DEPRESSION 15 0.0001
795 ILL-DEFINED DISORDER 4 0.0001
796 HIP ARTHROPLASTY 1 0.0001
797 FEELING HOT 4 0.0001
798 PRURITUS 25 0.0001
799 EMOTIONAL DISORDER 2 0.0001
800 LYMPHOMA 1 0.0001
801 HYPERSENSITIVITY 12 0.0001
802 LIMB DISCOMFORT 2 0.0001
803 ANKLE FRACTURE 1 0.0001
804 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
805 BASAL CELL CARCINOMA 1 0.0001
806 SWOLLEN TONGUE 2 0.0001
807 CYANOSIS 1 0.0001
808 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
809 PNEUMOTHORAX 1 0.0001
810 OBESITY 1 0.0001
811 HYPOTHYROIDISM 2 0.0001
812 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
813 NIGHT SWEATS 2 0.0001
814 MUSCLE TIGHTNESS 1 0.0001
815 MUSCULAR WEAKNESS 7 0.0001
816 SWELLING FACE 4 0.0001
817 PAIN IN EXTREMITY 18 0.0001
818 OSTEONECROSIS 2 0.0001
819 SEIZURE 7 0.0001
820 DRUG LEVEL INCREASED 1 0.0001
821 INFUSION RELATED REACTION 4 0.0001
822 EXPIRED PRODUCT ADMINISTERED 2 0.0001
823 EYE PRURITUS 2 0.0001
824 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
825 HEMIPARESIS 1 0.0001
826 RASH MACULAR 2 0.0001
827 INTENTIONAL PRODUCT MISUSE 5 0.0001
828 BURNING SENSATION 4 0.0001
829 HYPOXIA 2 0.0001
830 PANCREATITIS 3 0.0001
831 SLEEP DISORDER 4 0.0001
832 LYMPHADENOPATHY 2 0.0001
833 DRUG ERUPTION 1 0.0001
834 GALLBLADDER DISORDER 1 0.0001
835 GOUT 1 0.0001
836 GASTROENTERITIS VIRAL 1 0.0001
837 OEDEMA 3 0.0001
838 OSTEOMYELITIS 1 0.0001
839 UNDERDOSE 4 0.0001
840 DYSURIA 2 0.0001
841 ADVERSE EVENT 5 0.0001
842 CHEST PAIN 10 0.0001
843 EYE SWELLING 2 0.0001
844 URTICARIA 9 0.0001
845 ABDOMINAL DISCOMFORT 9 0.0001
846 ABDOMINAL PAIN UPPER 11 0.0001
847 EYE PAIN 3 0.0001
848 INTESTINAL OBSTRUCTION 2 0.0001
849 FOOT FRACTURE 1 0.0001
850 BLOOD URINE PRESENT 1 0.0001
851 GASTRIC ULCER 1 0.0001
852 DIZZINESS 26 0.0001
853 PRODUCT SUBSTITUTION ISSUE 3 0.0001
854 CHOLESTASIS 1 0.0001
855 HERNIA 1 0.0001
856 ERUCTATION 1 0.0001
857 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
858 ORAL HERPES 1 0.0001
859 DRUG DOSE OMISSION BY DEVICE 4 0.0001
860 CATARACT 3 0.0001
861 INJECTION SITE BRUISING 4 0.0001
862 DRY MOUTH 4 0.0000
863 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
864 INSOMNIA 13 0.0000
865 CARDIAC ARREST 4 0.0000
866 PERITONITIS 1 0.0000
867 RASH 21 0.0000
868 POLLAKIURIA 2 0.0000
869 KNEE ARTHROPLASTY 1 0.0000
870 HALLUCINATION, VISUAL 1 0.0000
871 IRRITABLE BOWEL SYNDROME 1 0.0000
872 LIVER FUNCTION TEST INCREASED 1 0.0000
873 HEADACHE 29 0.0000
874 CONDITION AGGRAVATED 14 0.0000
875 MENTAL DISORDER 2 0.0000
876 FEELING ABNORMAL 11 0.0000
877 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
878 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
879 ANXIETY 13 0.0000
880 TACHYCARDIA 4 0.0000
881 SOMNOLENCE 9 0.0000
882 MUSCLE TWITCHING 1 0.0000
883 ARTHRALGIA 18 0.0000
884 ABDOMINAL PAIN 10 0.0000
885 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
886 COGNITIVE DISORDER 2 0.0000
887 SWELLING 4 0.0000
888 BLOOD GLUCOSE INCREASED 8 0.0000
889 DYSPHAGIA 4 0.0000
890 RENAL CANCER 2 0.0000
891 BLOOD GLUCOSE DECREASED 2 0.0000
892 DIABETIC KETOACIDOSIS 1 0.0000
893 HEPATIC CANCER 1 0.0000
894 CEREBRAL INFARCTION 1 0.0000
895 INJECTION SITE URTICARIA 1 0.0000
896 PAIN 25 0.0000
897 AGEUSIA 1 0.0000
898 PNEUMONIA ASPIRATION 1 0.0000
899 HALLUCINATION 3 0.0000
900 UNEVALUABLE EVENT 3 0.0000
901 ABDOMINAL PAIN LOWER 1 0.0000
902 DRUG INEFFECTIVE 52 0.0000
903 HAEMATEMESIS 1 0.0000
904 CARDIOVASCULAR DISORDER 1 0.0000
905 HEPATITIS 1 0.0000
906 LOSS OF CONSCIOUSNESS 5 0.0000
907 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
908 HAEMATOMA 1 0.0000
909 EXPOSURE VIA SKIN CONTACT 1 0.0000
910 DIPLOPIA 1 0.0000
911 NERVOUSNESS 2 0.0000
912 PARAESTHESIA 6 0.0000
913 GASTRITIS 1 0.0000
914 NASOPHARYNGITIS 7 0.0000
915 DEPRESSED MOOD 2 0.0000
916 FEAR 1 0.0000
917 PAIN OF SKIN 1 0.0000
918 DISTURBANCE IN ATTENTION 2 0.0000
919 RASH PRURITIC 2 0.0000
920 PALLOR 1 0.0000
921 PNEUMONITIS 1 0.0000
922 TREATMENT NONCOMPLIANCE 2 0.0000
923 INFLUENZA LIKE ILLNESS 3 0.0000
924 FEELING COLD 1 0.0000
925 INFLUENZA 4 0.0000
926 OXYGEN SATURATION DECREASED 2 0.0000
927 PAIN IN JAW 1 0.0000
928 INCORRECT DOSE ADMINISTERED 8 0.0000
929 EYE IRRITATION 2 0.0000
930 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
931 PALPITATIONS 4 0.0000
932 ERYTHEMA 7 0.0000
933 JOINT SWELLING 4 0.0000
934 NO ADVERSE EVENT 6 0.0000
935 THERAPEUTIC RESPONSE DECREASED 2 0.0000
936 FEMUR FRACTURE 1 0.0000
937 PULMONARY EMBOLISM 3 0.0000
938 MIGRAINE 3 0.0000
939 DRUG DEPENDENCE 5 0.0000
940 DRUG INTOLERANCE 3 0.0000
941 RHINORRHOEA 2 0.0000
942 AMNESIA 2 0.0000
943 ALOPECIA 6 0.0000
944 IMPAIRED HEALING 1 0.0000
945 FLUSHING 3 0.0000
946 SINUSITIS 3 0.0000
947 VISION BLURRED 4 0.0000
948 DEVICE USE ERROR 1 0.0000
949 MYELOSUPPRESSION 1 0.0000
950 AGITATION 2 0.0000
951 HEPATIC FUNCTION ABNORMAL 1 0.0000
952 WEIGHT INCREASED 6 0.0000
953 ASTHMA 3 0.0000
954 HOT FLUSH 2 0.0000
955 INJECTION SITE PAIN 8 0.0000
956 DRUG INTERACTION 4 0.0000
957 ABORTION SPONTANEOUS 1 0.0000
958 EMOTIONAL DISTRESS 3 0.0000
959 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
960 OSTEOPOROSIS 1 0.0000
961 MYALGIA 4 0.0000
962 DEVICE LEAKAGE 1 0.0000
963 DEVICE DISLOCATION 1 0.0000
964 MUSCULOSKELETAL STIFFNESS 2 0.0000
965 DRUG WITHDRAWAL SYNDROME 2 0.0000
966 DRY SKIN 3 0.0000
967 COLITIS ULCERATIVE 1 0.0000
968 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
969 OROPHARYNGEAL PAIN 2 0.0000
970 BREAST CANCER 2 0.0000
971 BLOOD CHOLESTEROL INCREASED 1 0.0000
972 DISEASE RECURRENCE 1 0.0000
973 MULTIPLE SCLEROSIS 1 0.0000
974 DRY EYE 1 0.0000
975 ECZEMA 1 0.0000
976 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
977 MEDICATION ERROR 1 0.0000
978 RHEUMATOID ARTHRITIS 2 0.0000
979 NASAL CONGESTION 1 0.0000
980 DISCOMFORT 1 0.0000
981 INJECTION SITE PRURITUS 1 0.0000
982 HEPATIC ENZYME INCREASED 1 0.0000
983 INJECTION SITE REACTION 1 0.0000
984 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
985 HYPOAESTHESIA 2 0.0000
986 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
987 DRUG ABUSE 1 0.0000
988 OVERDOSE 1 0.0000